J&J
-
-
-
FDA grants conditional approval for J&J’s innovative bispecific antibody medicine
USA —The US Food and Drug Administration (FDA) has granted conditional approval for a cutting-edge medicine designed to combat multiple myeloma, extending a lifeline to…
-
Johnson & Johnson sued by Kenyan consumer advocacy group over the sale of talc-based baby powder
KENYA — The African Centre for Corrective and Preventive Action (ACCPA) has sued U.S.-based multinational corporation, Johnson & Johnson (J&J), over the continued sale of…
-
Johnson & Johnson reportedly targeting a US$40 billion valuation for consumer health unit Kenvue
USA — Johnson & Johnson is aiming for a valuation of US$40 billion for its consumer health unit, Kenvue, according to sources familiar with the…
-
Johnson & Johnson reports 10% sales increase in the U.S. and raises dividend
USA — Johnson & Johnson, the multinational healthcare company, has reported first-quarter results, with sales growth driven by strong demand for its cancer drugs and…
-
J&J to pay US$8.9 billion to settle legal claims regarding talcum powder
USA — Johnson & Johnson has taken a significant step towards resolving the allegations that its baby powder containing talc has caused cancer by earmarking…
-
Sanofi’s global head of R&D leaves for a similar role at J&J
FRANCE — Sanofi’s global head of R&D, John Reed has stepped down from his role in the company to join Johnson & Johnson, where he’ll…
-
DePuy Synthes to pay US$9.75 million to settle surgeon kickbacks case
USA — DePuy Synthes, a subsidiary of healthcare company Johnson & Johnson has agreed to pay nearly US$10 million to settle allegations that it violated…
-
J&J & SciBase collaborate to develop skin-screening AI to predict eczema in newborns
USA — SciBase, a developer of augmented intelligence-based solutions for skin disorders has signed a collaboration agreement with Johnson & Johnson Consumer to develop an…